Comparison of the efficacy of different mTOR inhibitors for the treatment of prostate cancer

被引:0
|
作者
D'Abronzo, Leandro Salati
Beggs, Ryan
Bose, Swagata
Ghosh, Paramita
机构
关键词
D O I
10.1158/1078-0432.MECHRES-A52
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A52
引用
收藏
页数:2
相关论文
共 50 条
  • [1] mTOR inhibitors for treatment of low-risk prostate cancer
    Liss, Michael A.
    Rickborn, Lanette
    DiGiovanni, John
    Bacich, Dean
    DeGraffenried, Linda A.
    Parihar, Manish
    Thompson, Ian M.
    Sharp, Zelton Dave
    MEDICAL HYPOTHESES, 2018, 117 : 63 - 68
  • [2] mTOR Inhibitors in the Treatment of Cancer
    Ozcan, Ozge
    Dikmen, Miris
    MARMARA PHARMACEUTICAL JOURNAL, 2015, 19 (03) : 290 - 297
  • [3] mTOR inhibitors in the treatment of cancer
    Fasolo, Angelica
    Sessa, Cristiana
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (11) : 1717 - 1734
  • [4] Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer
    Masiello, David
    Mohi, M. Golam
    McKnight, Nicole C.
    Smith, Bradley
    Neel, Ben G.
    Balk, Steven P.
    Bubley, Glenn J.
    CANCER BIOLOGY & THERAPY, 2007, 6 (02) : 195 - 201
  • [5] mTOR Inhibitors in the Treatment of Breast Cancer
    Vinayak, Shaveta
    Carlson, Robert W.
    ONCOLOGY-NEW YORK, 2013, 27 (01): : 38 - +
  • [6] The promise of mTOR inhibitors in the treatment of colorectal cancer
    Kim, Dae-Dong
    Eng, Cathy
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1775 - 1788
  • [7] Perspectives on mTOR Inhibitors for Castration-Refractory Prostate Cancer
    Burgio, Salvatore L.
    Fabbri, Francesco
    Seymour, Ian J.
    Zoli, Wainer
    Amadori, Dino
    De Giorgi, Ugo
    CURRENT CANCER DRUG TARGETS, 2012, 12 (08) : 940 - 949
  • [8] Prostate cancer stem cells display low mTOR activity and resistance to mTOR inhibitors in hypoxia
    Marhold, Maximilian
    Tomasich, Erwin
    Hofbauer, Guenther
    Krainer, Michael
    Horak, Peter
    CANCER RESEARCH, 2012, 72
  • [9] Signaling inhibitors in the treatment of prostate cancer
    Hudes, GR
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (02) : 159 - 172
  • [10] Angiogenesis inhibitors in the treatment of prostate cancer
    Clara Hwang
    Elisabeth I Heath
    Journal of Hematology & Oncology, 3